In male rodents, the arginine-vasopressin-immunoreactive (AVP-ir) neurones of the bed nucleus of the stria terminalis (BNST) and medial amygdala are controlled by plasma testosterone levels (decreased after castration and restored by exogenous testosterone). AVP transcription in these nuclei is increased in adulthood by a synergistic action of the androgenic and oestrogenic metabolites of testosterone and, accordingly, androgen and oestrogen receptors are present in both BNST and medial amygdala. We used knockout mice lacking a functional aromatase enzyme (ArKO) to investigate the effects of a chronic depletion of oestrogens on the sexually dimorphic AVP system. Wild-type (WT) and ArKO male mice were perfused 48 h after an i.c.v. colchicine injection and brain sections were then processed for AVP immunocytochemistry. A prominent decrease (but not a complete suppression) of AVP-ir structures was observed in the BNST and medial amygdala of ArKO mice by comparison with the WT. Similarly, AVP-ir fibres were reduced in the lateral septum of ArKO mice and but not in the medial preoptic area, a region where the AVP system is not sexually dimorphic in rats. No change was detected in the supraoptic and suprachiasmatic nuclei. However, a decrease in AVP-ir cell numbers was however, detected in one subregion of the paraventricular nucleus. These data support the hypothesis that the steroid-sensitive sexually dimorphic AVP system of the mouse forebrain is mainly under the control of aromatized metabolites of testosterone.
In rodents, parts of the arginine-vasopressin (AVP) neuronal system are sexually dimorphic and sensitive to sex steroids (1) . For example, the bed nucleus of the stria terminalis (BNST) and the medial amygdala (2) contain more AVPimmunoreactive (AVP-ir) cells in males than in females and projections from these nuclei to the lateral septum are denser in males than in females (3, 4) . The AVP cells and fibres located in these brain regions are involved in the control of a variety of social behaviours in mammals (5, 6) .
In both male and female adult rat, AVP expression in the BNST and medial amygdala is enhanced by testosterone: gonadectomy inhibits mRNA expression and AVP immunoreactivity in both nuclei and they are restored by treatment with exogenous testosterone (7) . The contribution of testosterone metabolites to the regulation of the AVP system has also been investigated in the adult rat. Oestradiol (E 2 ), when given in association with dihydrotestosterone (DHT), strongly enhances the AVP mRNA expression in the medial amygdala and BNST, whereas E 2 alone is less effective and DHT has no effect (8, 9) . These studies, as well as studies performed on other classes of vertebrates (10, 11) , suggest that the brain aromatization of testosterone is a key process controlling the action of this steroid on the limbic vasopressin/vasotocin systems. This hypothesis is also supported by the presence of oestrogen receptors of the alpha and beta subtype in these brain regions and, specifically, in AVP neurones (12) (13) (14) .
The sexual dimorphism of the AVP system is organized perinatally by testosterone secreted by the male gonads (15) . It has been assumed that the aromatization of testosterone into oestrogen also plays a key role in these organizational effects, but this notion had not been experimentally tested until recently (16) . The aim of the present study was to test the possible involvement of the aromatase enzyme in the control of the organization and activation of the AVP system in aromatase-knockout mice (17) that lack a functional aromatase gene and therefore are not able of converting testosterone into E 2 . We focused attention on the medial amygdala and BNST, two AVP-producing nuclei in which AVP transcription has been shown to be controlled by sex steroids in several mammalian species.
Materials and methods

Animals
This study was performed on male aromatase knockout (ArKO, n=8) mice and the corresponding wild-type (WT, n=7) mice (average age 15 weeks; average weight 34 g) that were generated by targeted disruption of exons 1 and 2 of the Cyp19 gene (17) . Heterozygous males and females the C57Bl6 strain were bred to generate WT and homozygous-null (ArKO) offspring. Mice were genotyped by polymerase chain reaction analysis of tail DNA (18) . All breeding and genotyping were performed at the School of Veterinary Medicine, University of Liège, Belgium.
Colchicine injections
Approximately one half of the subjects (4 ArKO and 3 WT) were anaesthetized with 0.4-0.5 ml of a mixture of xylazine-ketamine and positioned in a stereotaxic frame (Kopf, Tujunga, CA, USA). They were then stereotaxically injected in the lateral ventricle with 5 ml of a colchicine solution (6 mg/ml) at 0.2 ml/min. Accuracy of the position of the injection cannula was controlled by observing the increase in pressure in the cannula when it entered the ventricle. In this way, it could be ascertained that all injections were actually made in the ventricle. In addition, the inspection of brain sections revealed no trace of damaged tissue around the lateral ventricle except for the penetration path of the needle.
Two days after the colchicine injection, all mice (whether they had received colchicine or not) were deeply anaesthetized with xylazine-ketamine and perfused through the heart with 4% paraformaldehyde and 0.1% glutaraldehyde in 100 mM phosphate buffer (PB), pH 7.2-7.4. Brains were dissected out of the skull and kept for 2 days in PB containing 30% sucrose. They were then frozen on dry ice and stored at x70 uC until used for immunohistochemistry.
Immunohistochemistry
Brains were cut in the coronal plane with a cryostat at 25 mm thickness. Every fourth section was stained for AVP by immunohistochemistry using the freefloating technique. Sections were immunostained by the indirect biotin-avidin system using a commercial AVP antibody (ICN Pharmaceuticals, CA, USA) at the dilution of 1 : 20 000. The antibody was replaced in a few control sections by normal goat serum to control for staining specificity. No signal was observed in these conditions. The same antibody has also been used previously to stain the AVP cells and fibres in rodent species (19, 20) . These studies also indicated that preadsorption of the primary antibody with its antigen suppresses all immunocytochemical staining in sections and that the antibody does not cross-react with related peptides such as oxytocin (19) .
One alternate set of sections was stained by toluidine blue to prepare a series of Nissl-stained section that were used for anatomical orientation. Identification of all structures was based on the atlas of the mouse brain (21) .
Data analysis
All sections were first coded so that the observer performing quantitative analyses was blind to the experimental treatments. Sections were first observed with a light microscope (Olympus BH-2, Olympus Italia, Milano, Italy). Selected fields were acquired by a CCD-camera (Hamamatsu C 4200, Hamamatsu Italia, Milano, Italy) connected to a Power PC Macintosh 4400 equipped with a digitizing board.
The density of staining in nuclei containing AVP-ir structures was measured with the NIH Image program (version 1.62, a public domain program written by W. Rasband at the US National Institutes of Health, Bethesda, MD, USA) by calculating in binary transformations of the images the fractional area (percentages of pixels) covered by these structures in predetermined fields as described in previous publications (22, 23) .
Two separate rostro-caudal levels (anterior and posterior) were studied in the lateral septum (levels corresponding to stereotaxic coordinates 0.62 and 0.14 relative to Bregma in the mouse brain atlas) and medial amygdala (x1.22 and x1.70 relative to Bregma) to control for homogeneity of AVP distribution in these large structures. The fractional area covered by AVP-ir structures was determined in the same manner in the BNST (x0.22 relative to Bregma), the medial preoptic area (x0.10 relative to Bregma) and the suprachiasmatic nucleus (x0.58 relative to Bregma).
In addition, immunoreactive cells were counted at three separate rostrocaudal levels in the paraventricular nucleus (PVN, corresponding to x0.70, x0.82 and x0.94 Bregma) and at four rostro-caudal levels in the supraoptic nucleus (corresponding to x0.70, x0.82, x0.94 and x1.06 Bregma) and total numbers of cells observed in the three/four sections were calculated. Within the PVN, three subregions were in addition considered separately at each rostrocaudal level based on the mouse brain atlas: the periventricular PVN, the paraventricular medial parvicellular nucleus and the paraventricular medial magnocellular nucleus (PaMM).
Statistical analysis
The results were analysed by two-way analysis of variance (ANOVA) with a mixed design using the two genotypes as independent factor and the different brain locations as repeated factor. When appropriate, post-hoc comparisons were carried out for each brain area by an adaptation of Student's t-test using the relevant residual mean square as basis for comparison of means. P<0.05 was considered statistically significant.
Results
No parvocellular AVP immunostained cell could be detected in the BNST and medial amygdala of the four WT and four ArKO mice that had not been injected with colchicine. A clear vasopressinergic innervation of the lateral septum was however, detected in the four WT mice but was not observed in the four ArKO males (P=0.0285 by Fisher's exact probability test). These data therefore suggested a major reduction of the AVP immunoreactivity in the knockout mice, a conclusion that was confirmed and extended in mice that had been pretreated with colchicine.
The qualitative observation of the immunostained sections obtained in colchicine-treated mice showed a perceptible decrease in the extension of AVP immunoreactivity in all limbic and some hypothalamic nuclei of ArKO mice compared to the WT mice (Fig. 1) . No large qualitative difference was in contrast detectable in the magnocellular nuclei (supraoptic nucleus, Fig. 2C ,D, and PVN), in the nucleus circularis ( Fig. 2A,B) one of the accessory magnocellular nuclei, and in the suprachiasmatic nucleus.
Measures of the fractional areas covered by immunoreactive structures confirmed the decreased immunoreactivity in most of these structures (Fig. 3A) . Analysis of these data by two-way ANOVA (Fig. 3B) . Vasopressin immunoreactivity in aromatase-knockout mice 973
Post-hoc testing indicated the origins of this interaction: AVP-ir cells were less numerous in ArKO than in the WT mice specifically in the PaMM but not in the other two subdivisions of the nucleus ( Figs 2E,F and 3B ).
Discussion
The present data confirm the existence of a limbic population of AVP neurones and fibres in the BST, medial amygdala and lateral septum of mice. These cell populations are not visible in the absence of pretreatment with colchicine, but became apparent when mice were pretreated with this agent blocking axonal transport. A similar increase in the density of AVP immunoreactive structures has been previously reported in mice following exposure to colchicine (24) .
Major differences in the distribution of AVP-ir structures were observed in ArKO mice by comparison with WT mice. These differences mostly concerned the limbic brain areas that either contain AVP parvocellular elements and/or received a dense innervation from these cell groups, but differences in immunoreactive cell numbers were also observed in a specific subregion of the PVN. In every case, the density of immunoreactive structures was markedly lower in mice that lack a functional oestrogen synthase.
In mice that had been not been pretreated with colchicine, very few immunoreactive structures were detected. AVP-ir fibres were only observed in the lateral septum of WT mice and a complete disappearance of these fibres was detectable in ArKO males. This decreased expression of AVP in ArKO mice was confirmed and extended in mice pretreated with colchicine. Following the blockade of axonal transport, immunoreactive cells became apparent in the BNST and medial amygdala and a high density of fibres was detected in several limbic and hypothalamic nuclei of WT mice, but they were far less prominent in ArKO mice.
Many of the brain areas expressing AVP contain androgen receptors as well as oestrogen receptors of the alpha and beta subtypes (ERa and ERb) and, in some cases, these steroid receptors are colocalized with AVP in specific subsets of neurones. For example, in the BNST of rats, more than 90% of the AVP-ir cells coexpress androgen receptors (25) . Similarly Axelson and Van Leeuwen (12) reported that all cells of the BNST that express neurophysin II, the carrier protein of AVP, also express ERa. The second ER (ERb) (26, 27) ; is also present in neurones of the rat BNST (14, 28) . The medial amygdala and medial preoptic areas are also well known targets for sex steroid hormones as demonstrated by the presence of binding sites in autoradiographic studies (29, 30) and confirmed more recently by immunocytochemistry and in situ hybridization visualizing, respectively, the protein and messenger RNA of these receptors (14, 28, 31, 32) .
Taken together, these data indicate that sex steroids may be able to control the AVP expression in parvocellular systems in a direct manner (i.e. by acting directly on AVP neurones). In agreement with this idea, a single oestrogen response element (ERE) is present in the distal 1.5 kb portion of a recently isolated 5.5 kb fragment of the AVP gene promoter. This ERE and sequences proximal to this element enhance AVP transcription by oestrogen mediated by both ERa and ERb (33) . Oestrogens can therefore mediate AVP expression in a direct manner. Although androgens synergize with oestrogens to increase transcription of this neuropeptide, the mechanism underlying this synergism has not been identified to our knowledge.
Several studies in adults have accordingly demonstrated that manipulations of the circulating levels of sex steroids markedly affect AVP expression in the BNST and medial amygdala both in rat (2, 34, 35) and mouse (36) . Less data are available for mice but one detailed study analysing the expression of the carrier protein of AVP, neurophysin II, indicated that expression of this protein is markedly decreased by castration and enhanced in hypogonadal mice (that are functionally castrated) by a treatment with either testosterone or oestradiol, but not with DHT or progesterone. It seems therefore that AVP expression in mice is activated by aromatizable androgens or oestrogens, exactly as in rats (37) . The fact that AVP expression was decreased but not suppressed in ArKO mice presumably reflects this dual control of AVP by oestrogens and by androgens: the former only was affected by the aromatase inactivation.
In addition, it has been shown in rats that neonatal steroids have permanent irreversible effects on AVP expression that explain, at least partly, the sex difference in AVP expression observed in adulthood (15) . The AVP-ir projections of the BNST and medial amygdala are much denser in males than in females, even if males and females are treated in adulthood with similar amounts of testosterone. This sex difference is established by an early action of testosterone in males. Male rats that are castrated at 3 months of age have more AVP-ir cells in the BNST and a higher density of AVP-ir fibres in the lateral septum than neonatally castrated male rats, whose cell numbers and fibre density do not differ from female rats that have been ovariectomized neonatally or at 3 months of age. In addition, males castrated on the day of birth or at 1 week after birth have less AVP-ir cells in the BNST and medial amygdala and a lower AVP-ir fibre density in the lateral septum than male rats castrated 3 weeks or 3 months after birth. Finally, testosterone propionate treatment at the seventh postnatal day significantly raises AVP-ir fibre density in the lateral septum of neonatally gonadectomized male and female rats and fully restores the number of AVP-ir cells in the BNST of neonatally castrated males (15) . Similar changes have been observed in the number of cells labelled for AVP mRNA and in the density of grains per labelled cell of the BNST and medial amygdala (38) . Combined, these data suggest that testosterone concentrations around the seventh postnatal day determine the sexual differentiation of AVP projections to the lateral septum in rats. Recent work indicates that these early effects of testosterone are actually mediated by its aromatized metabolites. The effects of testosterone can be mimicked by an early treatment with oestradiol benzoate but not with the nonaromatizable androgen, DHT propionate (16) . The effects of neonatal treatments with sex steroids on the development of the AVP-ir system in the mice brain have not been investigated to our knowledge; however, androgen availability and responsiveness are important regulatory factors for aromatase expression in the developing male mouse hypothalamus (39) .
We have demonstrated the existence of a major reduction in the expression of AVP affecting most parvocellular AVP cell populations and their projection areas. The deficits observed in ArKO mice specifically affected the cell populations (BNST and medial amygdala) and projections to the septum that were previously shown to be sexually dimorphic in the rat and mouse brain (2) (3) (4) . The only exception to this rule was observed in the anterior part of the medial amygdala where no significant difference between WT and ArKO mice could be detected in the percentage of area covered by AVP-ir structures. It must be noted that a trend towards a reduction was nevertheless observed in the ArKO mice. This difference did not reach statistical significance, possibly because levels of immunoreactivity are too low in this part of the amygdala and their measure therefore cannot reach a sufficient level of accuracy.
No sex difference has previously been reported in the expression of AVP in the suprachiasmatic nucleus and in its projection to the medial preoptic area in rats. Accordingly, no effect of the oestrogen depletion on the density of AVP-ir fibres was observed in the medial preoptic area but, surprisingly, a minor increase in the percentage of area covered by immunoreactive structures (cells and fibers) was detected in the suprachiasmatic nucleus. The mechanism that generated this difference between knockout and WT mice and its possible physiological relevance for the normal physiology remain unclear at present.
The lack of a sex difference in AVP innervation of the medial preoptic area might appear surprising at first sight given that this region is clearly implicated in the control of male reproductive behaviours including, but not limited to, copulatory behaviour that are obviously sexually differentiated. AVP is commonly thought to be involved in the control of these sexually dimorphic behaviours (40 -42) . If this control by AVP is differential in males and females, this is probably not due to a different rate of expression of the peptide. However, it must be noted that the expression of AVP receptors is sexually differentiated in the preoptic area of mice, with a significantly higher expression being observed in females than in males (43) , and its expression in the hamster is regulated by gonadal steroids (44) . A differential control of behaviour by AVP in males and females could thus be the consequence of the differential transduction of a same signal in both sexes. Interestingly, larger portions of the suprachiasmatic nucleus were covered by AVP-ir structures in ArKO than in WT mice.
It is interesting to note that the experimental effects affecting the suprachiasmatic to medial preoptic area vasopressinergic projection have a 'reversed' direction compared to the effects observed in the BNST and medial amygdala. More AVP receptors have been observed in the medial preoptic area of females compared to males (43) and a larger fraction of the suprachiasmatic nucleus is covered by AVP-ir structures in ArKO than in WT mice (present study). This pathway thus appears to react differentially to steroids compared with the limbic structures. Additional studies should be carried out to confirm these discrepancies and to investigate the mechanisms that separately control their development.
Although studies describing effects of steroids and sex differences affecting the AVP-ir structures mostly concerned the parvocellular part of the AVP system, some effects have also been reported in the magnocellular PVN (45) . Accordingly, in addition to the effects of the aromatase knockout on the limbic and hypothalamic parvocellular system, the present data demonstrate a significant decrease in the number of AVP-ir neurones of a specific portion of the PVN (PaMM), that has been previously demonstrated to contain a large number of cells expressing ERb receptors. Dense expression of ERb mRNA has been detected in very defined regions of the PVN, in particular in the dorso-and ventromedial parvocellular zone (involved in the regulation of the autonomic system) and in the magnocellular PVN. A comparatively low hybridization signal was detected in the other subregions of the PVN (14) .
The decreased number of AVP-ir neurones was specifically observed here in ArKO mice in the part of the PVN that exhibits a dense expression of ERb mRNA in rats (43) , suggesting that oestrogens could directly regulate the peptide in these magnocellular neurones. However, some discrepancies have been reported concerning the potential colocalization of ERb and AVP in the magnocellular PVN. One study described cells producing ERb mRNA as surrounding AVP-ir neurones (14) , whereas a similar investigation showed an extensive colocalization of AVP immunoreactivity and ERb mRNA (46) .
The analysis of ArKO mice strongly supports the concept that the functions of some of the AVP-ir neurones in the PVN are directly regulated by oestrogens. Their action could be mediated by ERb either directly (if there are colocalized with AVP) or indirectly. The specific role of these subpopulations that are affected in ArKO mice remains to be determined and, in particular, whether these neurones are part of the neurohypophyseal system should be tested. Why similar effects of the aromatase knockout were not observed in the supraoptic nucleus where anatomical relationships between ERb and AVP have also been demonstrated (13, 46) remains unexplained at present.
